title: Clinical and neuropsychological features of corticobasal degeneration.
abstract: In this paper, we review the history, clinical, cognitive, imaging and neuropathological features of corticobasal degeneration (CBD). Additionally, we report new findings on the neuropsychological profile of 14 patients with CBD compared to 14 with Alzheimer's disease. Increasing awareness of this disorder has led to the realization that specific cognitive and imaging changes are common with CBD degeneration and that these changes help with clinical diagnosis.
authors.affiliation: University of California San Francisco, Memory and Aging Center, 350 Parnassus Avenue, Suite 705, 94143, USA. nbelfor@memory.ucsf.edu
authors.forename: Nataliya
authors.initials: N
authors.lastname: Belfor
authors.forename: Serena
authors.initials: S
authors.lastname: Amici
authors.forename: Adam L
authors.initials: AL
authors.lastname: Boxer
authors.forename: Joel H
authors.initials: JH
authors.lastname: Kramer
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Gorno-Tempini
authors.forename: Howard J
authors.initials: HJ
authors.lastname: Rosen
authors.forename: Bruce L
authors.initials: BL
authors.lastname: Miller
mesh_terms: D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D001479:Basal Ganglia / Q000378:metabolism / Q000473:pathology; D001480:Basal Ganglia Diseases / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D015415:Biomarkers / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology; D003072:Cognition Disorders / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D006801:Humans
chemical_list: D015415:Biomarkers